When U.S. President Donald Trump last came to Canada for a Group of Seven summit, the enduring image was of him seated with ...

Read why DNOW's strong balance sheet and diversification mitigate risks but global uncertainty and tariffs keep it a Hold.

U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data ...